Mashup Score:77
LancetThe Lancet Rheumatology Home Page - 2 weeks
Mashup Score:77
# RA
Mashup Score:54
NatureWe recently nominated cytokine signaling through the Janus-kinase–signal transducer and activator of transcription (JAK/STAT) pathway as a potential AD drug target. As hydroxychloroquine (HCQ)...
-
Hydroxychloroquine significantly lowers Alzheimer’s and dementia risk. Study of g 109,124 #RA pts starting HCQ or MTX. showed an 8-16% lower risk. https://t.co/q516bZPOq5 https://t.co/q516bZPOq5 - view on twitter
More coverage:
#ra
Mashup Score:23
NatureWe recently nominated cytokine signaling through the Janus-kinase–signal transducer and activator of transcription (JAK/STAT) pathway as a potential AD drug target. As hydroxychloroquine (HCQ)...
-
Hydroxychloroquine significantly lowers Alzheimer’s and dementia risk. Study of g 109,124 #RA pts starting HCQ or MTX. showed an 8-16% lower risk. https://t.co/gV4AYHRwmU https://t.co/gV4AYHRwmU - view on twitter
More coverage:
#ra
Key Points. The complement system plays a pathophysiologic role in the synovium of early RA.Correlations were found between DAS28 and complement genes in the...
-
#ICYMI from V. Michael Holers @CUMedicalSchool | Analysis of #complement expression and biodistribution in the synovium of early #RheumatoidArthritis patients | #ReadTheJI #immunology #RheumTwitter #RA 👉 https://t.co/wL2mv0ctfc https://t.co/wL2mv0ctfc - view on twitter
Mashup Score:8
American College of RheumatologyACR Journals on Air Podcast - 2 weeks
Mashup Score:8
Listen to ACR Journals on Air, the ACR’s newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals: Arthritis...
-
NEW EPISODE! Guest Patricia Katz, MD, talks her latest AC&R published study, which examines self-reported sleep problems in patients w/#RA, including the prevalence & negative health implications of sleep apnea, RLS, & short sleep. Listen → https://t.co/xX94rJ9yJy @ACR_Journals https://t.co/xX94rJ9yJy - view on twitter
More coverage:
#ra
Mashup Score:8
American College of RheumatologyACR Journals on Air Podcast - 5 days
Mashup Score:8
Listen to ACR Journals on Air, the ACR’s newest podcast series featuring interviews, commentary, and analysis on research from our three peer-reviewed journals: Arthritis...
-
Self-reported sleep problems are common in patients with #RA. Listen as guest Dr. Patricia Katz discusses a new study that examines associated risks with common sleep disorders + some career advice in writing academic papers → https://t.co/xX94rJ9yJy @ACR_Journals https://t.co/xX94rJ9yJy - view on twitter
More coverage:
#ra
To depict the spectrum of rheumatoid arthritis (RA) in Egypt in relation to other universal studies to provide broad-based characteristics to this particular population....
-
Status of #RA; an Egyptian College of Rheumatology study of 10,364 pts from 26 centers. Mean age 45 yrs, Dz duration 6.4 yrs, onset age 38. (F:M 5.4:1) DAS28 was 4.4 & HAQ 0.95 RF+ 74%, CCP+ 67% Rx use: MTX 78%, HCQ 74%, steroids 71%, Biologics 11.6% https://t.co/19omwKqAQl https://t.co/19omwKqAQl - view on twitter
More coverage:
#ra
Introduction The aim of this work is to compare real-world outcomes of patients with rheumatoid arthritis (RA) receiving adalimumab (ADA) bio-originator (non-switchers) to those...
-
Rx failures w/ nonmedical switching of biosimilars may be Nocebo effect. 140 #RA pts, 51 non-switchers & 89 switchers. Non-switchers more likely to improve than switchers (68 vs 26%, p < 0.001) and less likely to worsen (1% vs 9%, p < 0.01). https://t.co/w8lnv1V5Pi https://t.co/w8lnv1V5Pi - view on twitter
More coverage:
#ra
Mashup Score:3
NRASBSRBR-RA research study into treatments for RA survey | NRAS - 2 weeks
Mashup Score:3
British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA) Research Study survey, in collaboration with...
-
In collaboration w/@BSRBR_RA we have developed a survey to understand importance of treatment for people living with #RheumatoidArthritis. This will help guide future research in #RA. If you’re UK based and have RA, pls take part in our survey: https://t.co/BoBD95M8pd https://t.co/BoBD95M8pd - view on twitter
Mashup Score:2
LinkeWireGlobal Rheumatoid Arthritis Treatment Market Size Research Report 2023 - 3 weeks
Mashup Score:2
Rising occurrence of rheumatoid arthritis because of shift toward unhealthy lifestyle as well asincreasing research & development activities for better...
-
Worldwide prevalence (major markets) of #RA was 4.9 million in 2020; the RA global treatment market is estimated at US $40.5 billion in 2021, and is expected to grow ~6% per year in the next decade. https://t.co/EtBQwru0uF https://t.co/EtBQwru0uF - view on twitter
More coverage:
#ra
Explore clinical research, expert reviews, and comment and opinion from The Lancet Rheumatology. A voice for rheumatology specialists...
Our February issue is live! Including immune-mediated necrotising #myopathy, #RA #ILD, #fatigue, plus much more! https://t.co/XGoKvOAJDo cover by Grace Russell (@Gracie_25) https://t.co/XGoKvOAJDo - view on twitter